Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the Company will ....
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advanced Enzyme Technologies Ltd has announced a conference call for analysts and investors scheduled for May 12, 2026 at 09:00 AM IST to discuss the company's financial results for Q4 and FY ended March 31, 2026. The call will feature participation from Whole-time Director Mr. Mukund Kabra and CFO Mr. Beni Prasad Rauka. This is a routine regulatory disclosure under SEBI LODR Regulation 30, informing the market about the earnings call schedule. Dial-in numbers and registration details have been provided for participants.
This is a standard procedural announcement with no direct impact on share price. It confirms the company will report Q4 and full-year FY2026 results ahead of the scheduled analyst call.